Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Where Are The Biosimilars?

Dec 14 2012

• By Michael McCaughan and Derrick Gingery

Related Content

Biosimilars Pathway Dilemma: When Should Sponsors Pick (k) Before (a)?

May 23 2011

Biosimilars: Inverting the Innovator Development Model

Feb 01 2012

Teva’s G-CSF Product Clears FDA, Leaving Appeal Of Biosimilar Pathway Uncertain

Sep 03 2012

Biosimilarity vs. “Cognitive Dissonance”: The Ongoing Challenges to New FDA Pathway

Sep 19 2012

Related Companies

Pfizer Inc.

Teva Pharmaceutical Industries Ltd.

Amgen, Inc.

Novartis AG

Additional Topics

Regulation BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window